K

Kezar Life Sciences

KZR

0.63350
USD
-0.0165
(-2.54%)
مفتوح الان
حجم التداول
468
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
56,647,868
أصول ذات صلة
RSG
3.220
(1.66%)
197.500 USD
S
SAR
-0.290
(-1.24%)
23.050 USD
الأخبار المقالات

العنوان: Kezar Life Sciences

القطاع: Healthcare
الصناعة: Biotechnology
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.